New Mexico Bill to Legalize Medical Psilocybin Approved by Third Senate Committe

A third Senate committee has given approval to legislation that would legalize medical psilocybin, the active compound found in psychedelic mushrooms.

On Monday, the Senate Finance Committee voted in favor of Senate Bill 219, the Medical Psilocybin Act,
four days after the measure was advanced by the Senate Judiciary Committee. In February, the bill received approval by the Senate Tax, Business and Transportation Committee. The proposal now advances to the full Senate for consideration.

The proposed law would allow those in New Mexico with certain behavioral health conditions, including major treatment-resistant depression, post-traumatic stress disorder, substance use disorders, end-of-life care, and other conditions approved by the Department of Health, to receive psilocybin-assisted treatment for certain behavioral health conditions. The measure would establish an advisory board, a treatment equity fund, and a research fund while also removing psilocybin from the state’s Controlled Substances Act to protect “qualified and registered patients, clinicians and producers,” according to a news release from Senate and House Democrats.
Continue reading

Florida Department of Health: State Has 902,566 Medical Marijuana Patients, Nearly 4% of Population

Nearly 4% of Florida’s population is registered as a medical marijuana patient, according to new data from state officials.

cannabis oil cbd

The Florida Department of Health reports that as of March 10, 902,566 individuals are qualified medical marijuana patients, representing 3.9% of the state’s 23.3 million residents.

This marks an increase of approximately 2,000 patients since the start of the year and 29,350 more patients compared to February 2024.
Continue reading

Mississippi Legislature Approves Bill Revising Medical Cannabis Possession Limits and Allowing Telehealth for Homebound Patients

Mississippi’s legislature has approved Senate Bill 2748, a measure that revises key aspects of the state’s medical marijuana program.

Under current law, a Mississippi Medical Cannabis Equivalency Unit (MMCEU) is defined as 3.5 grams of medical marijuana flower, one gram of concentrate, or 100 milligrams of THC in an infused product (patients are allowed to obtain up to 24 MMCEUs within a 30-day period). Senate Bill 2748 revises this definition for the latter two, specifying that one MMCEU now consists of one gram of total THC in a concentrate, or one gram of total THC in an infused product.

The legislation also allows telemedicine evaluations for medical marijuana recommendations, provided the patient is homebound or bedbound and has this status certified by a separate practitioner. Additionally, SB 2748 alters the licensing process for medical marijuana businesses, prohibiting applicants from seeking local zoning or permitting approvals until they have first secured a state license from either the Mississippi Department of Health or the Mississippi Department of Revenue.
Continue reading

Kansas Senate Committee Files Bill to Decriminalize Marijuana Possession

A Kansas Senate committee has introduced a bill that would eliminate criminal penalties for possessing small amounts of marijuana, marking another step toward potential reform in the state.

Filed today by the Senate Federal and State Affairs Committee, Senate Bill 295 would replace criminal charges for possessing a personal-use quantity of marijuana with a civil penalty. The measure comes just days after the same committee introduced a separate bill to legalize medical marijuana.

Under SB 295, individuals found with up to an ounce of marijuana would no longer face criminal prosecution. Instead, they would be subject to a civil fine, similar to a traffic ticket. Under current law, possessing even a single gram is punishable by a misdemeanor and up to six years in jail.
Continue reading

Idaho Legislature Approves Resolution to Strip Voters of Power to Legalize Marijuana, Placing it on 2026 Ballot

The Idaho Senate has passed House Joint Resolution 4, finalizing its approval by the Legislature and securing its place on the November 2026 general election ballot.

HJR 4, which previously passed the House 58 to 10, was given approval by the Senate along party lines, with all 29 Republicans supporting the proposal and the six Demcorats opposed.

If approved by voters next year, the resolution would amend the state constitution to give the Legislature exclusive authority over the legalization of marijuana and other psychoactive substances. This would eliminate the public’s ability to legalize such substances through ballot initiatives.
Continue reading

The Top Cannabis Studies Published So Far in 2025

The first few months of 2025 have already yielded a wide range of notable cannabis studies, exploring everything from its medical potential in brain health and pain management, to the effects of marijuana legalization laws.

Despite marijuana remaining illegal in many parts of the world and in much of the United States, researchers continue to explore marijuana’s therapeutic potential at a rapid pace, in addition to studying the societal impact on laws that legalize the plant. With that in mind, below are some of the most notable studies published so far this year, in no particular order.
Continue reading

New York Bill Would Require Cannabis Education in School Curriculum

A New York lawmaker has filed a new bill that would bring cannabis education into the classroom.

Assembly Bill 6749, introduced today by Assemblymember Tony Simone (D), would integrate comprehensive health education on cannabis use into the state’s school curriculum. The bill has been referred to the Education Committee for review.

The legislation would amend Section 804 of the New York Education Law to incorporate cannabis education into health programs. Continue reading

Connecticut Marijuana Sales Total $22.1 Million in February, Prices Down 13% From Previous Year

Connecticut marijuana retailers recorded $22,123,617 in total sales in February, with $16,232,103 from adult-use purchases and $5,891,514 from medical marijuana transactions.

A total of 617,747 marijuana products were sold last month, including 439,698 for recreational consumers and 178,049 for medical patients. This marks a slight increase from the 606,000 products sold in February 2024, even though overall revenue dipped slightly from the $23 million reported during the same period last year.

The average price per gram of marijuana in Connecticut continued its downward trend, reaching $10.58 in February. This represents a 13% drop from the $12.28 average recorded a year ago. However, prices remain above the low of $9.68 per gram record in September 2023.

Continue reading

New York Senate Committee Advances Bill to Protect Medical Marijuana Patients from Eviction

A bill to protect medical marijuana patients from eviction has been given approval by a key committee in the New York Legislature.

The New York Senate Standing Committee on Housing, Construction, and Community Development has approved Senate Bill 3689, moving it forward in the legislative process and closer to a full Senate vote.

Filed in January by Senators James Sanders Jr. (D), Robert Jackson (D), Brian Kavanagh (D), and John Liu (D), the measure would prohibit landlords from evicting tenants solely due to their certified use of medical marijuana. The bill, which amends New York’s Real Property Actions and Proceedings Law, would provide additional legal protections for tenants who are registered medical marijuana patients under state law.

Continue reading

Vermont Senators Introduces Bill to Expand Psychedelic Therapy Advisory Group

A bill introduced today in the Vermont Senate would extend and expand the state’s Psychedelic Therapy Advisory Working Group, which has been studying the potential therapeutic benefits of psychedelics for mental health treatment.

Vermont State Capitol Building.

Senate Bill 106, sponsored by Senators Gulick, Vyhovsky, and White, all Democrat, has been referred to the Senate Committee on Health and Welfare for further consideration.

If passed, the bill would continue the group’s work reviewing research on psychedelics, including their potential role in treating conditions such as depression and anxiety, particularly in patients with serious illnesses or nearing the end of life.
Continue reading